Login Register Cart 0
Generic placeholder image

Current Bioinformatics

Editor-in-Chief

ISSN (Print): 1574-8936
ISSN (Online): 2212-392X

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Screening and Analysis of Hypolipidemic Components from Shuangdan Capsule Based on Pancreatic Lipase

Author(s): Y.J. Qi*, H.N. Lu, Y.M. Zhao, Z. Wang, Y.J. Ji, N.Z. Jin and Z.R. Ma

Volume 15, Issue 5, 2020

Page: [478 - 492] Pages: 15

DOI: 10.2174/1574893615666200106113910

Price: $65

Abstract

Background: Some natural pancreatic lipase inhibitors with fewer side effects are proposed. As a traditional Chinese medicine, Shuangdan Capsule (SDC) has been used for the treatment of higher lipid in blood, which is mainly composed by Radix Salviae and Peony skin.

Objective: This work is aimed to investigate the molecular mechanism of the constituents from this SDC against metabolic disorders, the molecular flexibility and intermolecular interactional characteristics of these components in the active sites.

Methods: The small molecules were obtained from the Traditional Chinese Medicine Database TCM database, the systems-level pharmacological database for Traditional Chinese Medicine TCMSP server was used to calculate the ADME-related properties. Autodock Vina was used to perform virtual screening of the selected molecules and to return energy values in several ligand conformations. The network parameters were calculated using the network analyzer plug-in in Cytoscape.

Results: The most active six molecules are all enclosed by amino acids ASP79, TYR114, GLU175, PRO180, PHE215, GLY216 and LUE264, among which, hydrophobic interaction, hydrogen bond and repulsive forces play extremely important roles. It is worth noting that most of the local minima of molecular electrostatic potentials on van der Waals (vdW) surface are increased while the maxima negative ones are decreased simultaneously, implying that the electrostatic potential tends to be stable. From the topological analysis of the Protein-Protein Interaction (PPI) network, PNLIP related genes are also proved to be pivotal targets for hyperlipidemia, such as LPL, AGK, MGLL, LIPE, LIPF and PNPLA2. Further GO analysis indicated that lipophilic terpenoid compounds may reduce the blood lipid by taking part in the lipid catabolic process, the extracellular space and the cellular components of the extracellular region part and the triacylglycerol lipase activity.

Conclusion: This study provides some useful information for the development and application of natural hypolipidemic medcines. Further pharmacologically active studies are still needed both in vivo and in vitro.

Keywords: Pancreatic lipase, molecular docking, quantum chemical calculations, molecular electrostatic potential, proteinprotein interaction, hypolipidemic.

« Previous Next »
Graphical Abstract

[1]
Lunagariya NA, Patel NK, Jagtap SC, Bhutani KK. Inhibitors of pancreatic lipase: state of the art and clinical perspectives. EXCLI J 2014; 13: 897-921.
[PMID: 26417311]
[2]
Aronne LJ. Classification of obesity and assessment of obesity-related health risks. Obes Res 2002; 10(Suppl. 2): 105S-15S.
[http://dx.doi.org/10.1038/oby.2002.203] [PMID: 12490659]
[3]
Kopelman PG. Obesity as a medical problem. Nature 2000; 404(6778): 635-43.
[http://dx.doi.org/10.1038/35007508] [PMID: 10766250]
[4]
Antonopoulos AS, Oikonomou EK, Antoniades C, Tousoulis D. From the BMI paradox to the obesity paradox: the obesity-mortality association in coronary heart disease. Obes Rev 2016; 17(10): 989-1000.
[http://dx.doi.org/10.1111/obr.12440] [PMID: 27405510]
[5]
Shi Y, Burn P. Lipid metabolic enzymes: emerging drug targets for the treatment of obesity. Nat Rev Drug Discov 2004; 3(8): 695-710.
[http://dx.doi.org/10.1038/nrd1469] [PMID: 15286736]
[6]
Birari RB, Bhutani KK. Pancreatic lipase inhibitors from natural sources: unexplored potential. Drug Discov Today 2007; 12(19-20): 879-89.
[http://dx.doi.org/10.1016/j.drudis.2007.07.024] [PMID: 17933690]
[7]
Hochuli E, Kupfer E, Maurer R, Meister W, Mercadal Y, Schmidt K. Lipstatin, an inhibitor of pancreatic lipase, produced by Streptomyces toxytricini. II. Chemistry and structure elucidation. J Antibiot 1987; 40(8): 1086-91.
[http://dx.doi.org/10.7164/antibiotics.40.1086] [PMID: 3680019]
[8]
Kopelman P, Bryson A, Hickling R, et al. Cetilistat (ATL-962), a novel lipase inhibitor: a 12-week randomized, placebo-controlled study of weight reduction in obese patients. Int J Obes 2007; 31(3): 494-9.
[http://dx.doi.org/10.1038/sj.ijo.0803446] [PMID: 16953261]
[9]
Kaila B, Raman M. Obesity: a review of pathogenesis and management strategies. Can J Gastroenterol 2008; 22(1): 61-8.
[http://dx.doi.org/10.1155/2008/609039] [PMID: 18209783]
[10]
Buchholz T, Melzig MF. Polyphenolic Compounds as Pancreatic Lipase Inhibitors. Planta Med 2015; 81(10): 771-83.
[http://dx.doi.org/10.1055/s-0035-1546173] [PMID: 26132857]
[11]
Sreerama YN, Takahashi Y, Yamaki K. Phenolic antioxidants in some Vigna species of legumes and their distinct inhibitory effects on α-glucosidase and pancreatic lipase activities. J Food Sci 2012; 77(9): C927-33.
[http://dx.doi.org/10.1111/j.1750-3841.2012.02848.x] [PMID: 22889371]
[12]
Yuan Y, Wang Y, Huang M, et al. Development and characterization of molecularly imprinted polymers for the selective enrichment of podophyllotoxin from traditional Chinese medicines. Anal Chim Acta 2011; 695(1-2): 63-72.
[http://dx.doi.org/10.1016/j.aca.2011.04.007] [PMID: 21601031]
[13]
Wang S, Wang C, Zhao X, Mao S, Wu Y, Fan G. Comprehensive two-dimensional high performance liquid chromatography system with immobilized liposome chromatography column and monolithic column for separation of the traditional Chinese medicine Schisandra chinensis. Anal Chim Acta 2012; 713: 121-9.
[http://dx.doi.org/10.1016/j.aca.2011.10.062] [PMID: 22200318]
[14]
Liang J, Wu WY, Sun GX, et al. A dynamic multiple reaction monitoring method for the multiple components quantification of complex traditional Chinese medicine preparations: Niuhuang Shangqing pill as an example. J Chromatogr A 2013; 1294: 58-69.
[http://dx.doi.org/10.1016/j.chroma.2013.04.016] [PMID: 23647610]
[15]
Nakai M, Fukui Y, Asami S, et al. Inhibitory effects of oolong tea polyphenols on pancreatic lipase in vitro. J Agric Food Chem 2005; 53(11): 4593-8.
[http://dx.doi.org/10.1021/jf047814+] [PMID: 15913331]
[16]
Zhang Y, Xiao S, Sun L, et al. Rapid screening of bioactive compounds from natural products by integrating 5-channel parallel chromatography coupled with on-line mass spectrometry and microplate based assays. Anal Chim Acta 2013; 777: 49-56.
[http://dx.doi.org/10.1016/j.aca.2013.03.028] [PMID: 23622964]
[17]
Xie W, Zhao Y, Du L. Emerging approaches of traditional Chinese medicine formulas for the treatment of hyperlipidemia. J Ethnopharmacol 2012; 140(2): 345-67.
[http://dx.doi.org/10.1016/j.jep.2012.01.027] [PMID: 22306102]
[18]
Chen J, Deng J, Zhang Y, et al. Lipid-lowering effects of Danhong injection on hyperlipidemia rats. J Ethnopharmacol 2014; 154(2): 437-42.
[http://dx.doi.org/10.1016/j.jep.2014.04.023] [PMID: 24751362]
[19]
Yang HO, Ko WK, Kim JY, Ro HS. Paeoniflorin: an antihyperlipidemic agent from Paeonia lactiflora. Fitoterapia 2004; 75(1): 45-9.
[http://dx.doi.org/10.1016/j.fitote.2003.08.016] [PMID: 14693219]
[20]
Ru J, Li P, Wang J, et al. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines. J Cheminform 2014; 6: 13.
[http://dx.doi.org/10.1186/1758-2946-6-13] [PMID: 24735618]
[21]
Morris GM, Huey R, Lindstrom W, et al. AutoDock4 and Auto-DockTools4: Automated docking with selective receptor flexibility. J Comput Chem 2009; 30(16): 2785-91.
[http://dx.doi.org/10.1002/jcc.21256] [PMID: 19399780]
[22]
Seeliger D, de Groot BL. Ligand docking and binding site analysis with PyMOL and Autodock/Vina. J Comput Aided Mol Des 2010; 24(5): 417-22.
[http://dx.doi.org/10.1007/s10822-010-9352-6] [PMID: 20401516]
[23]
Frisch MJ, Trucks GW, Schlegel HB, et al. Montgomery JAJr, Peralta JE, Ogliaro F, Bearpark M, Heyd JJ,Brothers E, Kudin KN, Staroverov VN, Kobayashi R, Normand J, Raghavachari K, Rendell A, Burant JC, Iyengar SS, Tomasi J, Cossi M, Rega N, Millam JM, Klene M, Knox JE, Cross JB, Bakken V, Adamo C, Jaramillo J, Gomperts R, Stratmann RE, Yazyev O, Austin AJ, Cammi R, Pomelli C, Ochterski JW, Martin RL, Morokuma K, Zakrzewski VG, Voth GA, Salvador P, Dannenberg JJ, Dapprich S, Daniels AD, Farkas Ö, Foresman JB, Ortiz JV, Cioslowski J, Fox DJ Gaussian 09, Revision E01. Wallingford, CT: Gaussian, Inc. 2009.
[24]
Lu T, Chen F. Multiwfn: a multifunctional wavefunction analyzer. J Comput Chem 2012; 33(5): 580-92.
[http://dx.doi.org/10.1002/jcc.22885] [PMID: 22162017]
[25]
Shaji SK, Sunilkumar D, Mahalakshmi NV, Kumar GB, Nair BG. Analysis of microarray data for identification of key microRNA signatures in glioblastoma multiforme. Oncol Lett 2019; 18(2): 1938-48.
[http://dx.doi.org/10.3892/ol.2019.10521] [PMID: 31423264]
[26]
Soorni A, Borna T, Alemardan A, Chakrabarti M, Hunt AG, Bombarely A. Transcriptome landscape variation in the genus thymus. Genes 2019; 10(8) E620
[http://dx.doi.org/10.3390/genes10080620] [PMID: 31426352]
[27]
Luo JW, Zhang ZR, Gong T, Fu Y. One-step self-assembled nanomicelles for improving the oral bioavailability of nimodipine. Int J Nanomedicine 2016; 11: 1051-65.
[PMID: 27042060]
[28]
Shen X, Zhao Z, Wang H, Guo Z, Hu B, Zhang G. Elucidation of the anti-inflammatory mechanisms of Bupleuri and Scutellariae Radix using system pharmacological analyses. Mediators Inflamm 2017; 2017 3709874
[http://dx.doi.org/10.1155/2017/3709874] [PMID: 28190938]
[29]
Ji W, Gong BQ. Hypolipidemic activity and mechanism of purified herbal extract of Salvia miltiorrhiza in hyperlipidemic rats. J Ethnopharmacol 2008; 119(2): 291-8.
[http://dx.doi.org/10.1016/j.jep.2008.07.013] [PMID: 18691646]
[30]
Zhang Q, Chang Z, Yang J, Wang Q. Antiatherogenic property of triterpenoids-enriched extract from the aerial parts of Salvia miltiorrhiza. Phytother Res 2008; 22(8): 1040-5.
[http://dx.doi.org/10.1002/ptr.2426] [PMID: 18668491]
[31]
Devipriya B, Kumaradhas P. Molecular flexibility and the electrostatic moments of curcumin and its derivatives in the active site of p300: a theoretical charge density study. Chem Biol Interact 2013; 204(3): 153-65.
[http://dx.doi.org/10.1016/j.cbi.2013.05.002] [PMID: 23684744]
[32]
Liu TT, Huo XK, Tian XG, et al. Demethylbellidifolin isolated from Swertia bimaculate against human carboxylesterase 2: Kinetics and interaction mechanism merged with docking simulations. Bioorg Chem 2019; 90 103101
[http://dx.doi.org/10.1016/j.bioorg.2019.103101] [PMID: 31291611]
[33]
Lin LZ, Wang XM, Huang XL, Huang Y, Yang BJ. A new diterpenoid quinone dehydromiltirone. Yao Xue Xue Bao 1988; 23(4): 273-5.
[PMID: 3176980]
[34]
Song W, Ma YY, Miao S, et al. Pharmacological actions of miltirone in the modulation of platelet function. Acta Pharmacol Sin 2019; 40(2): 199-207.
[http://dx.doi.org/10.1038/s41401-018-0010-1] [PMID: 29795134]
[35]
Zhou X, Wang Y, Lee WY, et al. Miltirone is a dual inhibitor of P-Glycoprotein and cell growth in doxorubicin-resistant HepG2 Cells. J Nat Prod 2015; 78(9): 2266-75.
[http://dx.doi.org/10.1021/acs.jnatprod.5b00516] [PMID: 26339922]
[36]
Marrelli M, Grande F, Occhiuzzi MA, Maione F, Mascolo N, Conforti F. Cryptotanshinone and tanshinone IIA from Salvia milthorrhiza Bunge (Danshen) as a new class of potential pancreatic lipase inhibitors. Nat Prod Res 2019; 20: 1-4.
[http://dx.doi.org/10.1080/14786419.2019.1607337] [PMID: 31104489]
[37]
Chen Z, Xu H. Anti-inflammatory and immunomodulatory mechanism of Tanshinone IIA for Atherosclerosis. Evid Based Complement Alternat Med 2014; 2014 267976
[http://dx.doi.org/10.1155/2014/267976] [PMID: 25525444]
[38]
Shang Q, Xu H, Huang L. Tanshinone IIA: A Promising Natural Cardioprotective Agent. Evid Based Complement Alternat Med 2012; 2012 716459
[http://dx.doi.org/10.1155/2012/716459] [PMID: 22454677]
[39]
Jia L, Song N, Yang G, et al. Effects of Tanshinone IIA on the modulation of miR 33a and the SREBP 2/Pcsk9 signaling pathway in hyperlipidemic rats. Mol Med Rep 2016; 13(6): 4627-35.
[http://dx.doi.org/10.3892/mmr.2016.5133] [PMID: 27082100]
[40]
Tang F, Wu X, Wang T, et al. Tanshinone II A attenuates atherosclerotic calcification in rat model by inhibition of oxidative stress. Vascul Pharmacol 2007; 46(6): 427-38.
[http://dx.doi.org/10.1016/j.vph.2007.01.001] [PMID: 17337361]
[41]
Chen W, Tang F, Xie B, Chen S, Huang H, Liu P. Amelioration of atherosclerosis by tanshinone IIA in hyperlipidemic rabbits through attenuation of oxidative stress. Eur J Pharmacol 2012; 674(2-3): 359-64.
[http://dx.doi.org/10.1016/j.ejphar.2011.10.040] [PMID: 22088276]
[42]
Xu S, Liu Z, Huang Y, et al. Tanshinone II-A inhibits oxidized LDL-induced LOX-1 expression in macrophages by reducing intracellular superoxide radical generation and NF-κB activation. Transl Res 2012; 160(2): 114-24.
[http://dx.doi.org/10.1016/j.trsl.2012.01.008] [PMID: 22677363]
[43]
Liu Z, Wang J, Huang E, et al. Tanshinone IIA suppresses cholesterol accumulation in human macrophages: role of heme oxygenase-1. J Lipid Res 2014; 55(2): 201-13.
[http://dx.doi.org/10.1194/jlr.M040394] [PMID: 24302760]
[44]
Wang HQ, Yang LX, Chen XY, Yang PF, Chen RY. Chemical Constituents from Salvia przewalskii Root. Zhong Yao Cai 2015; 38(6): 1197-201.
[PMID: 26762059]
[45]
Kim HK, Woo ER, Lee HW, et al. The correlation of Salvia miltiorrhiza extract-induced regulation of osteoclastogenesis with the amount of components tanshinone I, tanshinone IIA, cryptotanshinone, and dihydrotanshinone. Immunopharmacol Immunotoxicol 2008; 30(2): 347-64.
[http://dx.doi.org/10.1080/08923970801949133] [PMID: 18569089]
[46]
Zhao W, Li C, Gao H, Wu Q, Shi J, Chen X. Dihydrotanshinone I attenuates atherosclerosis in ApoE-deficient mice: role of NOX4/NF-kappaB mediated lectin-like oxidized LDL receptor-1 (LOX-1) of the endothelium. Front Pharmacol 2016; 7: 418.
[http://dx.doi.org/10.3389/fphar.2016.00418] [PMID: 27891092]
[47]
Yamashita S, Ruscica M, Macchi C, Corsini A, Matsuzawa Y, Sirtori CR. Cholesteryl ester transfer protein: An enigmatic pharmacology - Antagonists and agonists. Atherosclerosis 2018; 278: 286-98.
[http://dx.doi.org/10.1016/j.atherosclerosis.2018.09.035] [PMID: 30347344]
[48]
Chen X, Yu J, Zhong B, et al. Pharmacological activities of dihydrotanshinone I, a natural product from Salvia miltiorrhiza Bunge. Pharmacol Res 2019; 145 104254
[http://dx.doi.org/10.1016/j.phrs.2019.104254] [PMID: 31054311]
[49]
Chen HC, Chen PY, Wu MJ, Tai MH, Yen JH. Tanshinone IIA Modulates Low Density Lipoprotein Uptake via Down-Regulation of PCSK9 Gene Expression in HepG2 Cells. PLoS One 2016; 11(9) e0162414
[http://dx.doi.org/10.1371/journal.pone.0162414] [PMID: 27617748]
[50]
Ren FD, Cao DL, Shi WJ, Gao HF. A theoretical prediction of the relationships between the impact sensitivity and electrostatic potential in strained cyclic explosive and application to H-bonded complex of nitrocyclohydrocarbon. J Mol Model 2016; 22(4): 97.
[http://dx.doi.org/10.1007/s00894-016-2967-3] [PMID: 27029622]
[51]
Vijayalakshmi KP, Suresh CH. Theoretical studies on the carcinogenic activity of diol epoxide derivatives of PAH: proton affinity and aromaticity as decisive descriptors. Org Biomol Chem 2008; 6(23): 4384-90.
[http://dx.doi.org/10.1039/b813008f] [PMID: 19005598]
[52]
Abraham CS, Muthu S, Prasana JC, et al. Computational evaluation of the reactivity and pharmaceutical potential of an organic amine: A DFT, molecular dynamics simulations and molecular docking approach. Spectrochim Acta A Mol Biomol Spectrosc 2019; 222 117188
[http://dx.doi.org/10.1016/j.saa.2019.117188] [PMID: 31176999]
[53]
Gad El-Hak ASM, Mohammed AAK, Abdel Hakiem AF, Mahfouz RM. Molecular conformation, vibrational spectroscopic and NBO analysis of atenolol and atenolol-hydrochlorothiazide cocrystals. Spectrochim Acta A Mol Biomol Spectrosc 2019; 222 117200
[http://dx.doi.org/10.1016/j.saa.2019.117200] [PMID: 31176161]
[54]
ElKhattabi S, Hachi M, Fitri A, et al. Theoretical study of the effects of modifying the structures of organic dyes based on N,N-alkylamine on their efficiencies as DSSC sensitizers. J Mol Model 2019; 25(1): 9.
[http://dx.doi.org/10.1007/s00894-018-3888-0] [PMID: 30603796]
[55]
Abu El-Reash GM, El-Gammal OA, Radwan AH. Molecular structure and biological studies on Cr(III), Mn(II) and Fe(III) complexes of heterocyclic carbohydrazone ligand. Spectrochim Acta A Mol Biomol Spectrosc 2014; 121: 259-67.
[http://dx.doi.org/10.1016/j.saa.2013.10.048] [PMID: 24247099]
[56]
Kosar B, Albayrak C. Spectroscopic investigations and quantum chemical computational study of (E)-4-methoxy-2-[(p-tolylimino)methyl]phenol. Spectrochim Acta A Mol Biomol Spectrosc 2011; 78(1): 160-7.
[http://dx.doi.org/10.1016/j.saa.2010.09.016] [PMID: 20940104]
[57]
Abu El-Reash GM, El-Gammal OA, Ghazy SE, Radwan AH. Characterization and biological studies on Co(II), Ni(II) and Cu(II) complexes of carbohydrazones ending by pyridyl ring. Spectrochim Acta A Mol Biomol Spectrosc 2013; 104: 26-34.
[http://dx.doi.org/10.1016/j.saa.2012.11.008] [PMID: 23274253]
[58]
Rezaei Tavirani M, Rezaei Tavirani M, Vafaee R. Interaction Network Prediction and Analysis of Anorexia Nervosa. Iran J Child Neurol 2019; 13(3): 45-54.
[PMID: 31327968]
[59]
Zhang G, He P, Tan H, et al. Integration of metabolomics and transcriptomics revealed a fatty acid network exerting growth inhibitory effects in human pancreatic cancer. Clin Cancer Res 2013; 19(18): 4983-93.
[http://dx.doi.org/10.1158/1078-0432.CCR-13-0209] [PMID: 23918603]
[60]
Lai Y, Zhang F, Nayak TK, Modarres R, Lee NH, McCaffrey TA. Detecting discordance enrichment among a series of two-sample genome-wide expression data sets. BMC Genomics 2017; 18(Suppl. 1): 1050.
[http://dx.doi.org/10.1186/s12864-016-3265-2] [PMID: 28198679]
[61]
Li S, Xue X, Yang X, Zhou S, Wang S, Meng J. A network pharmacology approach used to estimate the active ingredients of moutan cortex charcoal and the potential targets in hemorrhagic diseases. Biol Pharm Bull 2019; 42(3): 432-41.
[http://dx.doi.org/10.1248/bpb.b18-00756] [PMID: 30828075]
[62]
Kim SA, Lee HJ, Ahn KS, et al. Paeonol exerts anti-angiogenic and anti-metastatic activities through downmodulation of Akt activation and inactivation of matrix metalloproteinases. Biol Pharm Bull 2009; 32(7): 1142-7.
[http://dx.doi.org/10.1248/bpb.32.1142] [PMID: 19571375]
[63]
Ye S, Liu X, Mao B, Yang L, Liu N. Paeonol enhances thrombus recanalization by inducing vascular endothelial growth factor 165 via ERK1/2 MAPK signaling pathway. Mol Med Rep 2016; 13(6): 4853-8.
[http://dx.doi.org/10.3892/mmr.2016.5135] [PMID: 27082415]
[64]
Ma L, Chuang CC, Weng W, et al. Paeonol protects rat heart by improving regional blood perfusion during no-reflow. Front Physiol 2016; 7: 298.
[http://dx.doi.org/10.3389/fphys.2016.00298] [PMID: 27493631]
[65]
Kim SH, Kim SA, Park MK, et al. Paeonol inhibits anaphylactic reaction by regulating histamine and TNF-alpha. Int Immunopharmacol 2004; 4(2): 279-87.
[http://dx.doi.org/10.1016/j.intimp.2003.12.013] [PMID: 14996419]
[66]
Terawaki K, Noguchi M, Yuzurihara M, Omiya Y, Ikarashi Y, Kase Y. Keishibukuryogan, a traditional Japanese medicine, inhibits platelet aggregation in guinea pig whole blood. Evid Based Complement Alternat Med 2015; 2015 295706
[http://dx.doi.org/10.1155/2015/295706] [PMID: 26379740]
[67]
Zhang JY, Lei L, Shang J, et al. Local application of paeonol prevents early restenosis: a study with a rabbit vein graft model. J Surg Res 2017; 212: 278-87.
[http://dx.doi.org/10.1016/j.jss.2016.11.020] [PMID: 28550918]
[68]
Li S, Wang L, Du Z, et al. Identification of the lipid-lowering component of triterpenes from Alismatis rhizoma based on the MRM-based characteristic chemical profiles and support vector machine model. Anal Bioanal Chem 2019; 411(15): 3257-68.
[http://dx.doi.org/10.1007/s00216-019-01818-x] [PMID: 31089788]

Rights & Permissions Print Cite
Article Metrics
19
1
© 2024 Bentham Science Publishers | Privacy Policy